GGrantIndex
← Search

EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF NATALIZUMAB FOLLOWING

$8,899M01FY2007RRNIH

Children'S Research Institute, Washington DC

Investigators

Linked publications & trials

View original record on NIH RePORTER →